Mark T. Phelan, President and CEO of Accel Entertainment, Inc. (NYSE:ACEL), filed a Form 4 on November 4, 2026, disclosing the sale of 25,000 shares of Class A-1 Common Stock on November 2, 2026, under a pre-established Rule 10b5-1 trading plan.
Adam Crystal, President of R&D at Tango Therapeutics, Inc. (NASDAQ:TNGX), filed a Form 4 on November 4, 2026, disclosing transactions in common stock executed on November 2, 2026, under a Rule 10b5-1 trading plan.
Jessica Newcomb, Principal Accounting Officer of Tango Therapeutics, Inc., filed a Form 4 on November 4, 2026, disclosing two open-market sales of common stock totaling 7,031 shares executed on November 2, 2026, under a pre-established Rule 10b5-1 trading plan.
Old National Bancorp /IN/ Chief Financial Officer John V. Moran filed a Form 4 on November 4, 2026, disclosing a sale of common stock executed on November 3, 2026.
Director and 10% owner Mitchell Jacobson filed a Form 4 with the SEC on November 4, 2026, disclosing a disposition of 72,386 shares of MSC Industrial Direct Co., Inc. Class A Common Stock on November 3, 2026.
Columbia Sportswear Company President Peter J. Bragdon filed a Form 4 on November 4, 2026, disclosing transactions in Columbia Sportswear common stock dated November 2, 2026, including an option exercise and an open-market sale.
Timothy P. Boyle, Chairman and CEO of Columbia Sportswear Co, filed a Form 4 on November 4, 2026, disclosing a disposition of 19,728 shares of common stock on November 2, 2026, via a gift transaction at a price of $0.
Columbia Sportswear Company EVP and COO Lisa Kulok filed a Form 4 on November 4, 2026, disclosing the exercise of 6,857 employee stock options and same-day sale of those shares on November 2, 2026.
Columbia Sportswear Company President of the Columbia Brand, Joseph P. Boyle, filed a Form 4 on November 4, 2026, disclosing option exercises and an open-market sale of common stock executed on November 2, 2026.
Jim A. Swanson, Executive Vice President and CFO of Columbia Sportswear Co, filed a Form 4 on November 4, 2026, disclosing option exercises and an open-market sale of common stock that occurred on November 3, 2026.